Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1173033rdf:typepubmed:Citationlld:pubmed
pubmed-article:1173033lifeskim:mentionsumls-concept:C0003062lld:lifeskim
pubmed-article:1173033lifeskim:mentionsumls-concept:C0001128lld:lifeskim
pubmed-article:1173033lifeskim:mentionsumls-concept:C0201734lld:lifeskim
pubmed-article:1173033lifeskim:mentionsumls-concept:C0056852lld:lifeskim
pubmed-article:1173033lifeskim:mentionsumls-concept:C0220874lld:lifeskim
pubmed-article:1173033pubmed:issue2lld:pubmed
pubmed-article:1173033pubmed:dateCreated1975-5-27lld:pubmed
pubmed-article:1173033pubmed:abstractTextThe study of the biotransformation of 2-(N,N-dimethylaminoethanol)-cyclohexylpropionate-meleate acid (cyprodenate, Actebral), a psychotonic brain stimulant, was carried out on two species of animals (rats and pigs) with the aid of 14C-labelled molecules. Following i.v. administration in rats it was found that 14C-cyprodenate diffuses very rapidly to the principal organs (liver, brain, kidneys) preceding a hydrolysis which gives 14C-dimethylaminoethanol (DMAE). The latter undergoes N-oxidation but the major portion of DMAE goes directly into the metabolic cycle of the phospholipids up to the formation of 14C-choline, as shown in the metabolic scheme proposed by the authors that identifies the principal labelled intermediaries: 14C-phosphoryl-DMAE (P-DMAE), 14C-glycerophosphatidyl-N,N-dimethylethanolamine (GP-DMAE), 14C-glycerophosphatidyl-choline (GP-choline). Similar results were found with the oral administration of 14C-cyprodenate in pigs, thus showing a more intense participation of the product at the level of the intermediary metabolism of phospholipids, precursors of choline.lld:pubmed
pubmed-article:1173033pubmed:languageenglld:pubmed
pubmed-article:1173033pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1173033pubmed:citationSubsetIMlld:pubmed
pubmed-article:1173033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1173033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1173033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1173033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1173033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1173033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1173033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1173033pubmed:statusMEDLINElld:pubmed
pubmed-article:1173033pubmed:monthFeblld:pubmed
pubmed-article:1173033pubmed:issn0004-4172lld:pubmed
pubmed-article:1173033pubmed:authorpubmed-author:DormardYYlld:pubmed
pubmed-article:1173033pubmed:authorpubmed-author:Le FurJ MJMlld:pubmed
pubmed-article:1173033pubmed:authorpubmed-author:LevronJ CJClld:pubmed
pubmed-article:1173033pubmed:issnTypePrintlld:pubmed
pubmed-article:1173033pubmed:volume25lld:pubmed
pubmed-article:1173033pubmed:ownerNLMlld:pubmed
pubmed-article:1173033pubmed:authorsCompleteYlld:pubmed
pubmed-article:1173033pubmed:pagination201-7lld:pubmed
pubmed-article:1173033pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:1173033pubmed:meshHeadingpubmed-meshheading:1173033-...lld:pubmed
pubmed-article:1173033pubmed:meshHeadingpubmed-meshheading:1173033-...lld:pubmed
pubmed-article:1173033pubmed:meshHeadingpubmed-meshheading:1173033-...lld:pubmed
pubmed-article:1173033pubmed:meshHeadingpubmed-meshheading:1173033-...lld:pubmed
pubmed-article:1173033pubmed:meshHeadingpubmed-meshheading:1173033-...lld:pubmed
pubmed-article:1173033pubmed:meshHeadingpubmed-meshheading:1173033-...lld:pubmed
pubmed-article:1173033pubmed:meshHeadingpubmed-meshheading:1173033-...lld:pubmed
pubmed-article:1173033pubmed:meshHeadingpubmed-meshheading:1173033-...lld:pubmed
pubmed-article:1173033pubmed:meshHeadingpubmed-meshheading:1173033-...lld:pubmed
pubmed-article:1173033pubmed:meshHeadingpubmed-meshheading:1173033-...lld:pubmed
pubmed-article:1173033pubmed:meshHeadingpubmed-meshheading:1173033-...lld:pubmed
pubmed-article:1173033pubmed:meshHeadingpubmed-meshheading:1173033-...lld:pubmed
pubmed-article:1173033pubmed:meshHeadingpubmed-meshheading:1173033-...lld:pubmed
pubmed-article:1173033pubmed:meshHeadingpubmed-meshheading:1173033-...lld:pubmed
pubmed-article:1173033pubmed:meshHeadingpubmed-meshheading:1173033-...lld:pubmed
pubmed-article:1173033pubmed:meshHeadingpubmed-meshheading:1173033-...lld:pubmed
pubmed-article:1173033pubmed:meshHeadingpubmed-meshheading:1173033-...lld:pubmed
pubmed-article:1173033pubmed:year1975lld:pubmed
pubmed-article:1173033pubmed:articleTitlePharmacokinetic study of maleate acid of 2-(N,N-dimethylaminoethanol-14C1)-cyclohexylpropionate (cyprodenate) and of N,N-dimethylaminoethanol-14C1 in animals.lld:pubmed
pubmed-article:1173033pubmed:publicationTypeJournal Articlelld:pubmed